Quantification of the neuropathology of alcohol use disorder using tissue microarrays
Journal of Neuropathology & Experimental Neurology · 2026
DOI: 10.1093/jnen/nlaf147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2026. Verfasst von Jie Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Charles Perkins Centre and School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia. Hauptthemen laut MEDLINE: Alcoholism, Tissue Array Analysis, White Matter, Brain. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, NIH HHS, National Institutes of Health.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Alcohol use disorder (AUD) is characterized by an inability to stop consuming alcohol. Neuroimaging studies of patients with AUD show mild grey and white matter atrophy, while pathological studies suggest that atrophy is restricted to the white matter. The effects on individual brain cells are largely unknown. Mild neuronal loss has been described in the prefrontal cortex but this has not been consistent. Studies quantifying oligodendrocytes, astrocytes, and microglia are rare. These knowledge gaps impede therapeutic advancements. Here, we piloted the use of tissue microarrays, immunohistochemistry, and automated image analysis to systematically quantify cell profiles in human postmortem tissue. We sampled 173 grey and white matter cores across 5 cerebral regions from 4 male AUD cases and 4 age-matched controls. We found no obvious differences in the regional profiles of neurons, astrocytes, oligodendrocytes, or microglia. However, mean microglial densities across all regions were higher in AUD (P=.0024). There were visual signs of reactive astrocytosis in AUD cases but mean cell body sizes were unchanged. Our findings suggest that alcohol-related brain damage is not due to a loss of any of major cell classes. Larger studies focusing on subtype-specific markers and advanced image analysis tools are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Charles Perkins Centre and School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
- School of Life and Environmental Sciences and Charles Perkins Centre, Faculty of Science, The University of Sydney, Sydney, NSW, Australia.
- Departments of Pathology and Laboratory Medicine, Neurology, Neurosurgery, and Medicine, Rhode Island Hospital, Brown University Health, Alpert Medical School of Brown University, Providence, RI, United States.
- Department of Medicine, Rhode Island Hospital, Lifespan Academic Institutions, and the Warren Alpert Medical School of Brown University, Providence, RI, United States.
ORCID-Profile: Dhiraj Maskey, Caine C Smith, Julia C Stevens, Markus J Hofer, Suzanne M de la Monte, Greg Trevor Sutherland
Förderung
- NIAAA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Liu, J., Catanzariti, M. J., Nguyen-Hao, H. T., Novelli, M., Maskey, D., Smith, C. C., Stevens, J. C., Hofer, M. J., de la Monte, S. M., & Sutherland, G. T. (2026). Quantification of the neuropathology of alcohol use disorder using tissue microarrays. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlaf147
Vancouver
Liu J, Catanzariti MJ, Nguyen-Hao HT, Novelli M, Maskey D, Smith CC, et al. Quantification of the neuropathology of alcohol use disorder using tissue microarrays. Journal of Neuropathology & Experimental Neurology. 2026. doi:10.1093/jnen/nlaf147
BibTeX
@article{Liu2026,
author = {Liu, Jie and Catanzariti, Matthew J and Nguyen-Hao, Huang-Tuong and Novelli, Mario and Maskey, Dhiraj and Smith, Caine C and Stevens, Julia C and Hofer, Markus J and de la Monte, Suzanne M and Sutherland, Greg Trevor},
title = {Quantification of the neuropathology of alcohol use disorder using tissue microarrays},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2026},
doi = {10.1093/jnen/nlaf147}
}
EUVIMED